Data edition of
Residue An evidence-graded reference for peptide science

Ipamorelin clinical trials

Every study registered on ClinicalTrials.gov that lists Ipamorelin as an intervention, as of the data edition — what is being tested, in whom, by whom, and how far it has got.

Registered studies
3
Active or recruiting
1
Completed
2
With posted results
0
Planned or actual enrollment
489participants, summed
Registered studies of Ipamorelin by phase and status
PhaseStudiesBreakdown
Phase 2 2
2 completed, 0 active or recruiting, 0 stopped, 0 other
Observational 1
0 completed, 1 active or recruiting, 0 stopped, 0 other
Figure 1. 3 studies on ClinicalTrials.gov match the registry search ipamorelin. Multi-phase studies are counted at their highest phase. Open the full trial feed

Conditions studied

  1. Ileus1
  2. PTSD - Post Traumatic Stress Disorder1
  3. Cognitive Dysfunction1
  4. Brain Injury1
  5. Depression - Major Depressive Disorder1
  6. Suicidal Ideation1
  7. Gastrointestinal Dysmotility1

Lead sponsors

  1. Helsinn Therapeutics (U.S.), Inc2
  2. Axial Therapeutic Research1

The registry, study by study

Registration is not evidence of benefit; many registered studies never publish. Status and dates are as reported by sponsors to ClinicalTrials.gov.

Status
Phase

3 shown

Registered studies of Ipamorelin
StudyPhaseStatusStartnSponsor
NCT07717866Trifecta Research Study Observational Active, not recruiting Aug 2022 52 Axial Therapeutic Research
NCT01280344Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function Phase 2 Completed Apr 2011 320 Helsinn Therapeutics (U.S.), Inc
NCT00672074Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus Phase 2 Completed Apr 2008 117 Helsinn Therapeutics (U.S.), Inc

Run this search on ClinicalTrials.gov → Query term: ipamorelin